Advanced search
Start date

Investigation of peri/epicellular protein disulphide isomerase as a novel regulator of the platelet-endothelium interaction in normoglycaemia and Diabetes

Grant number: 20/15944-8
Support type:Scholarships in Brazil - Post-Doctorate
Effective date (Start): June 01, 2021
Effective date (End): May 31, 2023
Field of knowledge:Health Sciences - Medicine - Medical Clinics
Principal researcher:Francisco Rafael Martins Laurindo
Grantee:Renato Simões Gaspar
Home Institution: Instituto do Coração Professor Euryclides de Jesus Zerbini (INCOR). Hospital das Clínicas da Faculdade de Medicina da USP (HCFMUSP). Secretaria da Saúde (São Paulo - Estado). São Paulo , SP, Brazil


Diabetes is a chronic and epidemic disease with high socio-economical cost worldwide, being characterized by increased risk of cardiovascular disease (CVD) and thromboembolic event. Upon endothelial dysfunction, platelets bind to endothelial cells to precipitate thrombus formation in a process that is not fully understood. Specifically, it is still unclear which surface proteins regulate platelet-endothelium interaction. In this regard, our lab has shown that peri/epicellular (pec) protein disulphide isomerase A1 (pecPDI) influences adhesion and migration of vascular cells. Therefore we hypothesize that pecPDI may regulate adhesion molecules on the surface of endothelial cells and platelets that influence the binding of these cells in physiological and pathological settings. Moreover, previous evidence suggests PDI is involved in Diabetes, therefore the impact of pecPDI will be assessed in diabetic mice in vivo and hyperglycaemic cells in vitro. Our main goal is to examine if pecPDI regulates platelet-endothelium interaction in normoglycaemia and Diabetes. Specifically, we will assess if pecPDI inhibition or genetic deletion of PDI affects expression levels of adhesion proteins, such as integrin beta 3, platelet and endothelial cell adhesion molecule 1 (PECAM-1), intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1), in hyperglycaemic endothelial cells in vitro; which adhesion molecules are targeted by pecPDI and how does pecPDI influence platelet-endothelium interaction in normo and Hyperglycaemia. Finally we will assess the importance of PDI to modulate platelet-endothelium interaction and thrombus formation in diabetic mice using intravital microscopy. Our lab is uniquely positioned to study how pecPDI associates with adhesion molecules, given the extensive techniques developed throughout decades of intensive scientific output. Altogether, the elucidation of novel molecules regulated by pecPDI, as well as mechanistic basis for platelet-endothelium interaction in normoglycaemia and Diabetes will expand the relevance of pecPDI to cell function and potentially lead to novel targets to treat and prevent thrombotic diseases in Diabetes. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
GASPAR, RENATO S.; MANSILLA, SANTIAGO; VIEIRA, VICTOR A.; SILVA, LUDMILA B. DA; GIBBINS, JONATHAN M.; CASTRO, LAURA; TROSTCHANSKY, ANDRES; PAES, ANTONIO MARCUS DE A.. The protein disulphide isomerase inhibitor CxxCpep modulates oxidative burst and mitochondrial function in platelets. Free Radical Biology and Medicine, v. 172, p. 668-674, . (20/15944-8)

Please report errors in scientific publications list by writing to: